Accepting Cases

Viberzi Lawsuits

Patients who developed pancreatitis while taking Viberzi are filing lawsuits against the drug’s maker. People whose loved ones suffered pancreatitis while taking Viberzi are also suing. Viberzi lawsuits claim Allergan failed to warn doctors that Viberzi increases the risk of pancreatitis in patients who don’t have a gallbladder.

*UPDATE: One of Drugwatch’s legal partners is accepting cases on behalf of people who suffered pancreatitis while prescribed Viberzi.

People without their gallbladder who take Viberzi are at an increased risk for pancreatitis. The condition can be deadly.

Viberzi (eluxadoline) lawsuits say the drug’s manufacturer failed to warn of this potential risk.

Lawyers handling Viberzi lawsuits accuse the drug maker of marketing a dangerous product. They claim the company promoted Viberzi’s safety without adequate testing.

Viberzi lawsuits are in the beginning stages. This means there have been no trials, verdicts or large mass tort settlements.

Did you develop pancreatitis while taking Viberzi? Get a Free Case Review

Why People File Viberzi Lawsuits

People are suing Viberzi’s manufacturer because they or a loved one developed pancreatitis while taking Viberzi. Pancreatitis is inflammation of the pancreas.

Abdominal pain, back pain, fast heart rate and fever are symptoms of pancreatitis. Others include loss of appetite, weight loss, excessive sweating and nausea and vomiting.

Some Viberzi users with pancreatitis needed hospitalization. Most of these patients were missing a gallbladder. Two of the patients died.

Viberzi lawsuits seek compensation for:
  • Medical expenses
  • Pain and suffering
  • Lost wages
  • Loss of earning capacity
  • Diminished quality of life

FDA Viberzi Pancreatitis Warning

The U.S. Food and Drug Administration issued a safety communication in March 2017. It warned Viberzi causes an increased risk of pancreatitis in people without their gallbladder.

The agency looked at reports from the time it approved the drug in May 2015 through February 2017. The FDA found it had received 120 reports of serious cases of pancreatitis or death.

“Among the 68 patients who reported their gallbladder status, 56 of them did not have a gallbladder and received the currently recommended dosage of Viberzi.”

Source: U.S. Food and Drug Administration

A total of 76 patients needed hospitalization. Two of those patients died. They did not have a gallbladder.

Steps for Filing a Viberzi Lawsuit

There are several steps involved in filing an injury lawsuit. It is important to speak with a qualified lawyer. A product liability attorney is the most knowledgeable professional in this area.

Steps for filing an injury lawsuit include:
  1. Get a diagnosis
  2. Speak with a lawyer
  3. Get medical records
  4. File a claim

When to File a Viberzi Claim: Statute of Limitations

The time limit for filing a personal injury claim can vary. Most states allow for two years to file a claim. Others allow three or more years.

Florida, for example, has a statute of limitations for injury claims of four years.

The statute of limitations can start at three different times:
  • The date when the injury occurred
  • The date on which the plaintiff should have reasonably discovered the injury
  • The date the injury was actually discovered

Injured patients should also be aware of notifications issued by the manufacturer. Notifications that a product is defective can start the clock ticking on statute of limitations.

In Viberzi cases, this might include the date the FDA informed the public about the drug’s link to pancreatitis. The FDA issued this notice on March 15, 2017.

Statute of limitations can be tricky. Patients should speak with a qualified attorney as soon as possible to determine how long they have to file a lawsuit.

Manufacturers Responsible for Viberzi

Allergan manufacturers Viberzi.

Allergan Logo

Actavis acquired Allergan in March 2015. The pharmaceutical company took on the Allergan name in June 2015.

Allergan has its U.S. headquarters in Irvine, California. In 2017, the drug manufacturer brought in $15.94 billion.

Accusations Against Viberzi’s Manufacturer

People filing Viberzi lawsuits accuse the manufacturer of being negligent. They say the company marketed a dangerous product.

They blame the company for failing to warn doctors of a potential link between Viberzi use and pancreatitis.

Before the FDA warned of Viberzi’s dangers in 2017, doctors considered the IBS-D drug safe for patients without a gallbladder.

Viberzi lawsuits point to a lack of studies to determine the actual risks in people without their gallbladder.

Viberzi Settlements or Verdicts

There have been no verdicts or settlements involving Viberzi and its possible link to pancreatitis.

Viberzi lawsuits are just starting out. Lawyers are working to determine what happened and whether there was a way to avoid the injury.

They are gathering evidence to support their claims. Claims may include liability, negligence and resulting harm.

Generally, lawyers are not sure how a group of lawsuits will turn out until one or more cases go to court.

Did you develop pancreatitis while taking Viberzi? Get a Free Case Review

Class Actions Involving Viberzi

There are no Viberzi class action lawsuits in the U.S. Instead, lawyers are accepting individual Viberzi lawsuits.

If enough lawsuits arise, a judicial panel may decide to join the lawsuits in one court. The panel would then create a multidistrict litigation.

Grouping the cases in this way can help move them through the court faster and with more efficiency.

Please seek the advice of a medical professional before making health care decisions.

Related Pages

Kristin Compton's background is in legal studies. She worked as a paralegal before joining Drugwatch as a writer and researcher. She was also a member of the National Association of Legal Assistants. A mother and longtime patient, she has firsthand experience of the harmful effects prescription drugs can have on women and their children. Some of her qualifications include:

  • Bachelor of Arts in Legal Studies | Pre-Law from University of West Florida
  • Past employment with The Health Law Firm and Kerrigan, Estess, Rankin, McLeod & Thompson LLC
  • Personal experience battling severe food allergies, asthma and high-risk pregnancies

4 Cited Research Articles

  1. serious pancreatitis with irritable bowel drug Viberzi (eluxadoline) in patients without a gallbladder. Retrieved from
  2. FDA. (2015, May 27). Approval Package for Application Number: 206940Orig1s000. Center for Drug Evaluation and Research. Retrieved from
  3. FDA. (2015, May 27). Application Number: 206940Orig1s000 Labeling. Center for Drug Evaluation and Research. Retrieved from
  4. Allergan. (n.d.). Company Profile. Retrieved from
View All Sources
Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(855) 781-7449

To contact Drugwatch Managing Editor Kevin Connolly, call (855) 839-9780.